Sanofi-Aventis Shakes Up Top Management

1 Comment

jean-claude-leroyIn a very terse statement, the drugmaker says its top legal and financial officer has stepped down, and that two execs will inherit each of his former roles. The resignation of Jean-Claude Leroy (pictured left), who spent 23 years with the company, comes just one week after former Glaxo exec Chris Viehbacher became ceo.

There was no explanation offered for the departure or the usual platitudes about devoted service. Laurence Debroux, the chief financial officer, and Karen Linehan, general counsel, who had reported to Leroy, will not join the executive committee and report directly to Viehabacher (here is the statement).

Jump to comments

Share

Comments

  1. Hallo,

    wir sind die Hurensohn AG, wir finden eure Pillen echt geil, vor allem die 12er Serie. Ist echt total fett, mann!

    Wie geht es euch denn eigentlich so? Schon mal wieder was Neues zusammengekocht? Falls Interesse, Probianten zu Handen uns schicken!

    Könnt ihr das per Schifffracht schicken? Funktioniert besser als sonst!

    Ansonsten ein frohes Bekommen!

    Haben euch lieb.

    Eure ewig treuen Pillenliebhaber

Leave a Comment


4 - three =

Subscribe

RSS Feed

Comments feed for this post only.

Clear

Clear

All rights reserved, UBM Canon. Copyright, UBM Canon.

Thanks for trying out the new Pharmalot printing tools. If you're got any suggestions for how we can help you print better, please let us know by clicking on the contact link at http://www.pharmalot.com/